Canadian Drugmaker Warned for Sterility, Verification, Procedural Issues

Drug Industry Daily
A A
The FDA issued a warning letter to Deserving Health International after an inspection of the drug manufacturer’s facility in Richmond, British Columbia in July revealed sterility problems, failure to verify the identity of drug components and other significant violations.

To View This Article:

Login

Subscribe To Drug Industry Daily